Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics

David J. Wilkinson, Maria del Carmen Arques, Carmen Huesa, Andrew D. Rowan

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Cartilage destruction is a key characteristic of arthritic disease, a process now widely established to be mediated by metzincins such as MMPs. Despite showing promise in preclinical trials during the 1990s, MMP inhibitors for the blockade of extracellular matrix turnover in the treatment of cancer and arthritis failed clinically, primarily due to poor selectivity for target MMPs. In recent years, roles for serine proteinases in the proteolytic cascades leading to cartilage destruction have become increasingly apparent, renewing interest in the potential for new therapeutic strategies that utilize pharmacological inhibitors against this class of proteinases. Herein, we describe key serine proteinases with likely importance in arthritic disease and highlight recent advances in this field.
Original languageEnglish
Pages (from-to)38-51
Number of pages14
JournalBritish Journal of Pharmacology
Volume176
Issue number1
Early online date23 Feb 2018
DOIs
Publication statusPublished - 31 Jan 2019

Cite this

Wilkinson, David J. ; Arques, Maria del Carmen ; Huesa, Carmen ; Rowan, Andrew D. / Serine proteinases in the turnover of the cartilage extracellular matrix in the joint : implications for therapeutics. In: British Journal of Pharmacology. 2019 ; Vol. 176, No. 1. pp. 38-51.
@article{74880c8817f341e1846c9a22f3a2b005,
title = "Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics",
abstract = "Cartilage destruction is a key characteristic of arthritic disease, a process now widely established to be mediated by metzincins such as MMPs. Despite showing promise in preclinical trials during the 1990s, MMP inhibitors for the blockade of extracellular matrix turnover in the treatment of cancer and arthritis failed clinically, primarily due to poor selectivity for target MMPs. In recent years, roles for serine proteinases in the proteolytic cascades leading to cartilage destruction have become increasingly apparent, renewing interest in the potential for new therapeutic strategies that utilize pharmacological inhibitors against this class of proteinases. Herein, we describe key serine proteinases with likely importance in arthritic disease and highlight recent advances in this field.",
author = "Wilkinson, {David J.} and Arques, {Maria del Carmen} and Carmen Huesa and Rowan, {Andrew D.}",
year = "2019",
month = "1",
day = "31",
doi = "10.1111/bph.14173",
language = "English",
volume = "176",
pages = "38--51",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley",
number = "1",

}

Serine proteinases in the turnover of the cartilage extracellular matrix in the joint : implications for therapeutics. / Wilkinson, David J.; Arques, Maria del Carmen; Huesa, Carmen; Rowan, Andrew D.

In: British Journal of Pharmacology, Vol. 176, No. 1, 31.01.2019, p. 38-51.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Serine proteinases in the turnover of the cartilage extracellular matrix in the joint

T2 - implications for therapeutics

AU - Wilkinson, David J.

AU - Arques, Maria del Carmen

AU - Huesa, Carmen

AU - Rowan, Andrew D.

PY - 2019/1/31

Y1 - 2019/1/31

N2 - Cartilage destruction is a key characteristic of arthritic disease, a process now widely established to be mediated by metzincins such as MMPs. Despite showing promise in preclinical trials during the 1990s, MMP inhibitors for the blockade of extracellular matrix turnover in the treatment of cancer and arthritis failed clinically, primarily due to poor selectivity for target MMPs. In recent years, roles for serine proteinases in the proteolytic cascades leading to cartilage destruction have become increasingly apparent, renewing interest in the potential for new therapeutic strategies that utilize pharmacological inhibitors against this class of proteinases. Herein, we describe key serine proteinases with likely importance in arthritic disease and highlight recent advances in this field.

AB - Cartilage destruction is a key characteristic of arthritic disease, a process now widely established to be mediated by metzincins such as MMPs. Despite showing promise in preclinical trials during the 1990s, MMP inhibitors for the blockade of extracellular matrix turnover in the treatment of cancer and arthritis failed clinically, primarily due to poor selectivity for target MMPs. In recent years, roles for serine proteinases in the proteolytic cascades leading to cartilage destruction have become increasingly apparent, renewing interest in the potential for new therapeutic strategies that utilize pharmacological inhibitors against this class of proteinases. Herein, we describe key serine proteinases with likely importance in arthritic disease and highlight recent advances in this field.

U2 - 10.1111/bph.14173

DO - 10.1111/bph.14173

M3 - Review article

VL - 176

SP - 38

EP - 51

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -